{"context":{"query":">>uniprot>>bindingdb","source_dataset":"uniprot","target_dataset":"bindingdb"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]Q16665,1,Q16665,124,4]["},"schema":"id|ligand_name|target_name|target_source_organism|ki|ic50|kd|ec50","mappings":[{"input":"Q16665","source":"Q16665|Hypoxia-inducible factor 1-alpha","targets":["200233|AB00053810_11::cid_2016|Cystic fibrosis transmembrane conductance regulator|Human||||>50000","22595|3-[2-(4-tert-butylphenoxy)acetamido]benzoic acid::Compound DLC27|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||29000 nM||","22984|(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione::Adriamycin::Adriblastina::CHEMBL53463::Doxil::Doxorubicin|7-dehydrocholesterol reductase|Homo sapiens||10000 nM||","271458|2-(4-hydroxy-1-methyl-2-oxo-7-phenoxy-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 1|Hypoxia-inducible factor 1-alpha|Homo sapiens||||5350 nM","271459|2-(1-(cyclopropylmethyl)-4-hydroxy-2-oxo-7-phenoxy-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 2|Hypoxia-inducible factor 1-alpha|Homo sapiens||||5000 nM","271460|2-(4-hydroxy-1-methyl-2-oxo-6-phenoxy-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 5|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4000 nM","271461|2-(6-((1H-indol-1-yl)sulfonyl)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 7|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6830 nM","271462|2-(4-hydroxy-1-methyl-7-(naphthalen-2-yloxy)-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 8|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1630 nM","271463|2-(4-hydroxy-1-methyl-6-(naphthalen-2-yloxy)-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 9|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2520 nM","271464|2-(6-(benzhydryl(methyl)carbamoyl)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 11|Hypoxia-inducible factor 1-alpha|Homo sapiens||||10230 nM","271465|2-(7-(3-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 12|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4240 nM","271466|2-(7-(4-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 13|Hypoxia-inducible factor 1-alpha|Homo sapiens||||7100 nM","271467|2-(7-(2,3-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 14|Hypoxia-inducible factor 1-alpha|Homo sapiens||||10250 nM","271468|2-(7-(2,4-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 15|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6920 nM","271469|2-(7-(2,6-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 16|Hypoxia-inducible factor 1-alpha|Homo sapiens||||8830 nM","271470|2-(7-(3,4-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 17|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3160 nM","271471|2-(7-(3,5-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 18|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6280 nM","271472|2-(7-(2,5-difluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 19|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2260 nM","271473|2-(7-(3-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 20|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3750 nM","271474|2-(7-(4-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 21|Hypoxia-inducible factor 1-alpha|Homo sapiens||||5750 nM","271475|2-(7-(5-chloro-2-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 22|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4180 nM","271476|2-(7-(2-chloro-6-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 23|Hypoxia-inducible factor 1-alpha|Homo sapiens||||9230 nM","271477|2-(7-(2-chloro-3-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 24|Hypoxia-inducible factor 1-alpha|Homo sapiens||||9530 nM","271478|2-(7-(4-chloro-3-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 25|Hypoxia-inducible factor 1-alpha|Homo sapiens||||10150 nM","271479|2-(7-(3-chloro-5-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 26|Hypoxia-inducible factor 1-alpha|Homo sapiens||||13500 nM","271480|2-(7-(2-chloro-5-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 27|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6850 nM","271481|2-(7-(2-chloro-4-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 28|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1510 nM","271482|2-(7-(3-chloro-4-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 29|Hypoxia-inducible factor 1-alpha|Homo sapiens||||10190 nM","271483|2-(7-(2,3-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 30|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1970 nM","271484|2-(7-(2,4-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 31|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4150 nM","271485|2-(7-(2,6-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 32|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3630 nM","271486|2-(7-(3,4-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 33|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2560 nM","271487|2-(7-(3,5-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 34|Hypoxia-inducible factor 1-alpha|Homo sapiens||||20200 nM","271488|2-(7-(2,5-dichlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 35|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2250 nM","271489|2-(4-hydroxy-7-(4-methoxyphenoxy)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 36|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2950 nM","271490|2-(4-hydroxy-7-(3-methoxyphenoxy)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 37|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6260 nM","271491|2-(4-hydroxy-7-(2-methoxyphenoxy)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 38|Hypoxia-inducible factor 1-alpha|Homo sapiens||||8850 nM","271492|2-(6-fluoro-4-hydroxy-1-methyl-2-oxo-7-phenoxy-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 39|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4890 nM","271493|2-(4-hydroxy-1-methyl-2-oxo-7-(2-(trifluoromethoxy)phenoxy)-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 40|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4060 nM","271494|2-(1-(cyclopropylethyl)-4-hydroxy-2-oxo-7-phenoxy-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 42|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3340 nM","271495|2-(4-hydroxy-1-methyl-2-oxo-7-(pyridin-4-yloxy)-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 43|Hypoxia-inducible factor 1-alpha|Homo sapiens||||28900 nM","271496|2-(7-(2-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 45|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6020 nM","271497|2-(7-(3-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 46|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3610 nM","271498|2-(7-(4-fluorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 47|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3920 nM","271499|2-(7-(2-chlorophenoxy)-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid::US10065928, Example 48|Hypoxia-inducible factor 1-alpha|Homo sapiens||||6600 nM","332027|(E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (naphthalen-1-yl-methylene)- N-methylamino]ethyl}N- methylamino)acethydrazide::US10196346, Example 1|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2290 nM","332028|(E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{2- [N-(naphthalen-1-yl- methylene)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 2|Hypoxia-inducible factor 1-alpha|Homo sapiens||||17800 nM","332029|(E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2- [N-(naphthalen-1-yl- methylene)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 3|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2110 nM","332030|(E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{N-{2-[N- (naphthalen-1-yl- methylene)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 4|Hypoxia-inducible factor 1-alpha|Homo sapiens||||830 nM","332031|(E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N-{2- [N-(naphthalen-1-yl- methylene)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 5|Hypoxia-inducible factor 1-alpha|Homo sapiens||||780 nM","332032|(E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{2- [N-(3- trifluoromethylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 8|Hypoxia-inducible factor 1-alpha|Homo sapiens||||5230 nM","332033|(E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N-{2- [N-(3- trifluoromethylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 10|Hypoxia-inducible factor 1-alpha|Homo sapiens||||600 nM","332034|(E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(3- trifluoromethylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 11|Hypoxia-inducible factor 1-alpha|Homo sapiens||||170 nM","332035|(E)-N'-[(3-ethoxy-2- hydroxybenzal)methylene]- 2-{N-{2-[N-(4- isopropylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 13|Hypoxia-inducible factor 1-alpha|Homo sapiens||||800 nM","332036|(E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{N-{2-[N- (4-isopropylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 14|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1020 nM","332037|(E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{2-[N- (4-isopropylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 15|Hypoxia-inducible factor 1-alpha|Homo sapiens||||11200 nM","332038|(E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(4-isopropylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 17|Hypoxia-inducible factor 1-alpha|Homo sapiens||||560 nM","332039|(E)-N'-(3-bromo-6- hydroxybenzal)-2-{N-{2- [N-(4-isopropylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 18|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2280 nM","332040|(E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{2- [N-(3-methoxybenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 22|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2770 nM","332041|(E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N-{2- [N-(3-methoxybenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 23|Hypoxia-inducible factor 1-alpha|Homo sapiens||||760 nM","332042|(E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(3-methoxybenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 24|Hypoxia-inducible factor 1-alpha|Homo sapiens||||820 nM","332043|(E)-N'-(3-bromo-6- hydroxybenzal)-2-{N-{2- [N-(3-methoxybenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 25|Hypoxia-inducible factor 1-alpha|Homo sapiens||||7190 nM","332044|(E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{N-{2-[N- (4-cyanobenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 26|Hypoxia-inducible factor 1-alpha|Homo sapiens||||980 nM","332045|(E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{2- [N-(4-cyanobenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 27|Hypoxia-inducible factor 1-alpha|Homo sapiens||||7750 nM","332046|(E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (4-cyanobenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 28|Hypoxia-inducible factor 1-alpha|Homo sapiens||||8420 nM","332047|(E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2- [N-(4-cyanobenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 29|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2770 nM","332048|(E)-N'-(4-N,N-diethylamino- 2-hydroxybenzal)-2-{N-{2- [N-(4-cyanobenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 30|Hypoxia-inducible factor 1-alpha|Homo sapiens||||530 nM","332049|(E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (4-tert-butylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 31|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2760 nM","332050|(E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2-[N- (4-tert-butylbenzyl)-N- methylamino]ethyl}N- methylamino}acethydrazide::US10196346, Example 32|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1860 nM","332051|(E)-N'-(4-N,N-diethylamino- 2-hydroxybenzal)-2-{N-{3- [N-(4-tert-butylbenzyl)-N- methylamino]propyl}N- methylamino}acethydrazide::US10196346, Example 33|Hypoxia-inducible factor 1-alpha|Homo sapiens||||130 nM","47715|DEFEROXAMINE::DEFEROXAMINE MESYLATE::MLS000028713::N''-(5-azanylpentyl)-N-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-N''-oxidanyl-butanediamide;methanesulfonic acid::N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N''-(5-aminopentyl)-N''-hydroxybutanediamide;methanesulfonic acid::N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-keto-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-succinamide;mesylic acid::N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N''-(5-aminopentyl)-N''-hydroxybutanediamide;methanesulfonic acid::SMR000058548::cid_62881|Deoxyhypusine hydroxylase|Human||5000 nM||","482293|US10919843, Compound II|Hypoxia-inducible factor 1-alpha|Homo sapiens||||3200 nM","482294|US10919843, Compound III|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1700 nM","482295|US10919843, Compound IV|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1600 nM","482296|US10919843, Compound V|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1800 nM","482297|US10919843, Compound VI|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2800 nM","482298|US10919843, Compound VII|Hypoxia-inducible factor 1-alpha|Homo sapiens||||2900 nM","482299|US10919843, Compound VIII|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1400 nM","482300|US10919843, Compound IX|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1400 nM","482301|US10919843, Compound X|Hypoxia-inducible factor 1-alpha|Homo sapiens||||1200 nM","48235|MLS000541553::N,N-dimethyl-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine::N,N-dimethyl-6-phenyl-3-pyridin-2-yl-1,2,4-triazin-5-amine::SMR000126411::cid_6404645::dimethyl-[6-phenyl-3-(2-pyridyl)-1,2,4-triazin-5-yl]amine|Hypoxia-inducible factor 1-alpha|Homo sapiens||||7460 nM","48250|6-phenyl-N-prop-2-enyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine::6-phenyl-N-prop-2-enyl-3-pyridin-2-yl-1,2,4-triazin-5-amine::MLS000541554::N-allyl-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine::SMR000126412::allyl-[6-phenyl-3-(2-pyridyl)-1,2,4-triazin-5-yl]amine::cid_6413024|Hypoxia-inducible factor 1-alpha|Homo sapiens||||4620 nM","49766|MLS000708948::N-(3-imidazol-1-ylpropyl)-5-phenyl-1,2-oxazole-3-carboxamide::N-(3-imidazol-1-ylpropyl)-5-phenyl-isoxazole-3-carboxamide::N-[3-(1-imidazolyl)propyl]-5-phenyl-3-isoxazolecarboxamide::SMR000289715::cid_2962284|Hypoxia-inducible factor 1-alpha|Homo sapiens||||15800 nM","50005781|ALVESPIMYCIN::CHEBI:65324|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||3.6 nM||","50008935|(20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione::(4-Ethyl-4,9-dihydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-10-ylmethyl)-dimethyl-ammonium::(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3'',4'':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE::(S)-10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione::(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione::10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione::10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Topotecan)::10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione(Topotecan)::10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione::CHEMBL84::Hycamtin::TOPOTECAN::TOPOTECAN HYDROCHLORIDE::cid_60700|Cystic fibrosis transmembrane conductance regulator|Human||||>50000","50031514|CHEMBL3359141|Hypoxia-inducible factor 1-alpha|Homo sapiens||4300 nM||","50031515|CHEMBL3359142|Hypoxia-inducible factor 1-alpha|Homo sapiens||>30000||","50031516|CHEMBL3359143|Hypoxia-inducible factor 1-alpha|Homo sapiens||>30000||","50031517|CHEMBL3359144|Hypoxia-inducible factor 1-alpha|Homo sapiens||>30000||","50031518|CHEMBL3359145|Hypoxia-inducible factor 1-alpha|Homo sapiens||11400 nM||","50031519|CHEMBL3359146|Hypoxia-inducible factor 1-alpha|Homo sapiens||>30000||","50031520|CHEMBL3359147|Hypoxia-inducible factor 1-alpha|Homo sapiens||4700 nM||","50031521|CHEMBL3359148|Hypoxia-inducible factor 1-alpha|Homo sapiens||>30000||","50042874|2,2'-Bipyridin::2,2'-bipyridine::2,2'-bipyridyl::2,2'-dipyridine::2,2'-dipyridyl::2-(2-pyridyl)pyridine::CHEMBL39879::US10196346, Bipyridine::alpha,alpha'-bipyridine::alpha,alpha'-bipyridyl::alpha,alpha'-dipyridine::alpha,alpha'-dipyridyl::bpy|C-C chemokine receptor type 1|Homo sapiens||||31622.78 nM","50058752|CHEMBL3335630|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||0.470000 nM||","50058753|CHEMBL3335427|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||1.1 nM||","50058754|CHEMBL3335426|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||2.6 nM||","50058755|CHEMBL3335425|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||5.8 nM||","50058756|CHEMBL3335424|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||21 nM||","50058757|CHEMBL3335423|Endothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha|Homo sapiens||0.970000 nM||"]}]}